Replies to post #203030 on Biotech Values

[DewDiligence]

EYEG +126% on EGP-437collaboration with VRX in post-operative pain:

http://finance.yahoo.com/news/valeant-pharmaceuticals-eyegate-enter-licensing-123000666.html

VRX previously licensed the rights to EGP-437 in uveitis.